Erhard Bappert

USPTO Granted Patents = 9 (Patent Applications = 1)

CIPO Patents = 1

EPO Patents = 4 (Patent Applications = 5)

Average Co-Inventor Count = 5.4

ph-index = 1

Forward Citations = 9(Granted Patents)

Location History:

Weil am Rhein, DE (2015 - 2017)
Basel, CH (2012 - 2024)

Company Filing History:

Novartis Pharmaceuticals Corporation

patents

4. 1 out of 217

Actelion Pharmaceuticals Ltd

patents

Years Active: 2012-2024

Loading Chart...

9 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 12030855 - Process for making amino diaryl ethers and amino diaryl ethers hydrochloride salts (2024-07-09),

2. 11472771 - Process for making amino diaryl ethers and amino diaryl ethers hydrochloride salts (2022-10-18),

3. 9802887 - Process for the preparation of intermediates useful for the manufacture NEP inhibitors (2017-10-31),

4. 9403766 - Intermediates for producing NEP inhibitors or prodrugs thereof (2016-08-02),

5. 9227934 - Processes for producing NEP inhibitors or prodrugs thereof (2016-01-05),

6. 9085529 - Process for the preparation of intermediates useful for the manufacture NEP inhibitors (2015-07-21),

7. 9061973 - Processes for producing NEP inhibitors or prodrugs thereof (2015-06-23),

8. 8580974 - Processes (2013-11-12),

9. 8314238 - Process for the preparation of an enantiomeric trisubstituted 3,4-dihydro-isoquinoline derivative (2012-11-20),

Title: Erhard Bappert: Innovator in Amino Diaryl Ethers

Introduction

Erhard Bappert is a notable inventor based in Basel, Switzerland. He has made significant contributions to the field of chemistry, particularly in the development of amino diaryl ethers. With a total of nine patents to his name, Bappert's work has had a considerable impact on the pharmaceutical industry.

Latest Patents

Bappert's latest patents focus on a process for making amino diaryl ethers and their hydrochloride salts. The invention involves reducing a compound with hydrogen in the presence of a palladium catalyst and a suitable solvent. This process is crucial for synthesizing compounds that have various applications in medicinal chemistry.

Career Highlights

Throughout his career, Erhard Bappert has worked with prominent companies such as Novartis AG and Cellestia Biotech AG. His experience in these organizations has allowed him to refine his skills and contribute to innovative projects in the pharmaceutical sector.

Collaborations

Bappert has collaborated with notable professionals in his field, including David Hook and Daniel Kaufmann. These partnerships have further enhanced his research and development efforts.

Conclusion

Erhard Bappert's contributions to the field of chemistry, particularly through his patents and collaborations, highlight his role as an influential inventor. His work continues to shape advancements in the synthesis of important chemical compounds.

This text is generated by artificial intelligence and may not be accurate.